Advertisement
Screener

Biomea Fusion, Inc. (BMEA) Auditor

Biomea Fusion, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-24: Fiscal year end 2025-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location San Francisco, CA.
  • 2025-03-31: Fiscal year end 2024-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location San Francisco, CA.
  • 2024-03-28: Fiscal year end 2023-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location San Francisco, CA.
  • 2023-03-28: Fiscal year end 2022-12-31; Auditor DELOITTE & TOUCHE LLP; PCAOB firm ID 34; Location San Francisco, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-242025-12-31Deloitte & Touche LLP34San Francisco, CANo
2025-03-312024-12-31Deloitte & Touche LLP34San Francisco, CANo
2024-03-282023-12-31Deloitte & Touche LLP34San Francisco, CANo
2023-03-282022-12-31DELOITTE & TOUCHE LLP34San Francisco, CaliforniaNo
2022-02-282021-12-31DELOITTE & TOUCHE LLP34San Francisco, CaliforniaNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Equillium, Inc. (EQ)United States$0.109B-11.27
GENELUX Corp (GNLX)United States$0.110B-3.83
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
ProMIS Neurosciences Inc. (PMN)$0.102B
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Anixa Biosciences Inc (ANIX)United States$0.096B